Abstract: A pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein X is selected from a hydroxyl, a metal salt hydroxylate, an O-linked phosphoester, an O-linked phosphoramidite, an O-linked ester, an O-linked carbamate, an S-linked phosphothioate, or an N-linked phosphoramidite, and at least one pharmaceutically acceptable excipient selected from a cysteine compound, an amino acid, an N-acetyl amino acid, an acid or a salt thereof, or any combination thereof. The pharmaceutical composition can be used for the effective treatment of viral infections in humans and other animal species caused by viruses, in particular, RNA viruses and can be administered orally or parenterally.

Abstract: The present invention relates to compositions comprising a cyclicpeptide, a solvent and two or more hydroxylhydrocarbons, independently selected from i) ethanol and glycerol; or ii) ethanol and mannitol. Methods of treating diseased conditions using the compositions of the present invention are also provided in the present invention.

Abstract: A concentrated acetaminophen solution is provided that is dissolved in polyethylene glycol (PEG) with trace water. The acetaminophen is present in the PEG at a concentration of at least 200 mg per mL. The composition is useful to deliver or safely store concentrated doses of acetaminophen without degradation of the acetaminophen.